Sequential generation of cytokines during the initiative phase of inflammation, with reference to neutrophils

Inflammation Research

Volumn 47, Issue SUPPL. 3, 1998, Pages

  Matsukawa, A ^a   Yoshinaga, M ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

Author keywords

Cytokine; In vivo study; Inflammation; Interleukins; Neutrophils

Indexed keywords

CYTOKINE; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 1BETA; INTERLEUKIN 8; LIPOPOLYSACCHARIDE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTHRITIS; CONFERENCE PAPER; CONTROLLED STUDY; FEMALE; INFLAMMATION; NEUTROPHIL; NONHUMAN; RABBIT;

EID: 0031726586     PISSN: 10233830     EISSN: None     Source Type: Journal    
DOI: 10.1007/s000110050304     Document Type: Conference Paper

References (61)

1. Strieter RM, Kunkel SL, Bone RC. Role of tumor necrosis factor-α in disease states and inflammation. Crit Care Med 1993;21: S447-63.
2. Baggiolini M, Loetscher P, Moser B. Interleukin-8 and the chemokine family. Int J Immunopharmacol 1995;17:103-8.
3. Dinarello CA. Biologic basis for interleukin-1 in disease. Blood 1996;87:2095-147.
4. Fontana A, Hengartner H, Weber E, Fehr K, Grob PJ, Cohen G. Interleukin 1 activity in the synovial fluid of patients with rheumatoid arthritis. Rheumatol Int 1982;2:49-53.
5. Hopkins SJ, Meager A. Cytokines in synovial fluid: II. The presence of tumour necrosis factor and interferon. Clin Exp Immunol 1988;73:88-92.
6. Brennan FM, Zachariae CO, Chantry D, Larsen CG, Turner M, Maini RN, et al. Detection of interleukin 8 biological activity in synovial fluids from patients with rheumatoid arthritis and production of interleukin 8 mRNA by isolated synovial cells. Eur J Immunol 1990;20:2141-44.
7. Firestein GS, Berger AE, Tracey DE, Chosay JG, Chapman DL, Paine MM, et al. IL-1 receptor antagonist protein production and gene expression in rheumatoid arthritis and osteoarthritis synovium. J Immunol 1992;149:1054-62.
8. Di Giovine GF, Malawista SE, Thornton E, Duff GW. Urate crystals stimulate production of tumor necrosis factor alpha from human blood monocytes and synovial cells. Cytokine mRNA and protein kinetics, and cellular distribution. J Clin Invest 1991; 87:1375-81.
9. Terkeltaub R, Zachariae C, Santoro D, Martin J, Peveri P, Matsushima K. Monocyte-derived neutrophil chemotactic factor/ interleukin-8 is a potential mediator of crystal-induced inflammation. Arthritis Rheum 1991;34:894-903.
10. Wood DD, Ihrie EJ, Dinarello CA, Cohen PL. Isolation of an interleukin-1-like factor from human joint effusions. Arthritis Rheum 1983;26:975-83.
11. Hayashi H. The intracellular neutral SH-dependent protease associated with inflammatory reactions. Inter Rev Cytol 1975; 40:101-51.
12. Goto F, Goto K, Mori S, Ohkawara S, Yoshinaga M. Biosynthesis of interleukin-I β at inflammatory site in rabbits: kinetics and producing cells. Br J Exp Pathol 1989;70:597-606.
13. Matsukawa A, Mori S, Ohkawara S, Maeda T, Tanase S, Edamitsu S, et al. Production, purification and characterization of a rabbit recombinant IL-1 receptor antagonist. BiomedRes 1992;13:269-77.
14. Matsukawa A, Furukawa S, Ohkawara S, Takagi K, Yoshinaga M. Development of a neutralizing monoclonal antibody against rabbit IL-1 receptor antagonist and utilization for ELISA and measurement of masked IL-1 activity in biological materials. Immunol Invest 1994;23:129-42.
15. Matsukawa A, Yoshimura T, Maeda T, Ohkawara S, Takagi K, Yoshinaga M. Neutrophil accumulation and activation by homologous IL-8 in rabbits. IL-8 induces destruction of cartilage and production of IL-1 and IL-1 receptor antagonist in vivo. J Immunol 1995;154:5418-25.
16. Matsukawa A, Yoshimura T, Miyamoto K, Ohkawara S, Yoshinaga M. Analysis of the inflammatory cytokine network among TNFα, IL-1β, IL-1 receptor antagonist, and IL-8 in LPS-induced rabbit arthritis. Lab Invest 1997;76:629-38.
17. Yoshinaga M, Nakamura S, Hayashi H. Interaction between lymphocytes and inflammatory exudate cells. I. Enhancement of thymocyte response to PHA by product(s) of polymorphonuclear leukocytes and macrophages. J Immunol 1975;115:533-8.
18. Lloyd AR, Oppenheim JJ. Poly's lament: The neglected role of the polymorphonuclear neutrophil in the afferent limb of the immune response. Immunol Today 1992;13:169-72.
19. Cassatella MA. The production of cytokines by polymorphonuclear neutrophils. Immunol Today 1995;16:21-6.
20. Matsukawa A, Ohkawara S, Maeda T, Takagi K, Yoshinaga M. Production of IL-1 and IL-1 receptor antagonist and the pathological significance in lipopolysaccharide-induced arthritis in rabbits. Clin Exp Immunol 1993;93:206-11.
21. Haranaka K, Carswell EA, Williamson BD, Prendergast JS, Satomi N, Old LJ. Purification, characterization, and antitumor activity of nonrecombinant mouse tumor necrosis factor. Proc Natl Acad Sci USA 1986;83:3949-53.
22. Arend WP. Interleukin-1 receptor antagonist. Adv Immunol 1993;54:167-227.
23. Bazzoni F, Cassatella MA, Rossi F, Ceska M, Dewald B, Baggiolini M. Phagocytosing neutrophils produce and release high amounts of the neutrophil-activating peptide 1/interleukin 8. J Exp Med 1991;173:771-4.
24. Cassatella MA, Bazzoni F, Ceska M, Ferro I, Baggiolini M, Berton G. IL-8 production by human polymorphonuclear leukocytes. The chemoattractant formyl-methionyl-leucyl-phenylalanine induces the gene expression and release of IL-8 through a pertussis toxin-sensitive pathway. J Immunol 1992;148:3216-20.
25. Strieter RM, Kasahara K, Allen RM, Standiford TJ, Rolfe MW, Becker FS, et al. Cytokine-induced neutrophil-derived interleukin-8. Am J Pathol 1992;141:397-407.
26. Edamitsu S, Matsukawa A, Ohkawara S, Takagi K, Nariuchi H, Yoshinaga M. Role of TNFα, IL-1, and IL-1ra in the mediation of leukocyte infiltration and increased vascular permeability in rabbits with LPS-induced pleurisy. Clin Immunol Immunopathol 1995;75:68-74.
27. Mo J, Matsukawa A, Ohkawara S, Yoshinaga M. Involvement of TNFα, IL-1β and IL-1 receptor antagonist in LPS-induced rabbit uveitis. Exp Eye Res 1998;in press.
28. Kimura M, Matsukawa A, Ohkawara S, Takagi K, Yoshinaga M. Blocking of TNF-α and IL-1 inhibits leukocyte infiltration at early, but not at late stage of S. aureus-induced arthritis and the concomitant cartilage destruction in rabbits. Clin Immunol Immunopathol 1997;82:18-25.
29. Matsukaw A, Yoshimura T, Maeda T, Takahashi T, Ohkawara S, Yoshinaga M. Analysis of the cytokine network among TNFα, IL-1β, IL-8 and IL-1 receptor antagonist in monosodium urate crystal-induced rabbit arthritis. Lab Invest 1998;in press.
30. Pabst MJ, Johnson RBJ. Bacterial lipopolysaccharide: A mediator of inflammation. In: Henson PM, Murphy RC, editor. Handbook of inflammation 6. Mediator of the inflammatory process. Amsterdam: Elsevier, 1989:361-93.
31. Morrison DC, Ryan JL. Endotoxins and disease mechanisms. Annu Rev Med 1987;38:417-32.
32. Henderson B, Wilson M. Modulins: A new class of cytokine-inducing, pro-inflammatory bacterial virulence factor. Inflamm Res 1995;44:187-97.
33. Yoshimura T, Matsushima K, Oppenheim JJ, Leonard EJ. Neutrophil chemotactic factor produced by lipopolysaccharide (LPS)-stimulated human blood mononuclear leukocytes: partial characterization and separation from interleukin 1 (IL 1). J Immunol 1987;139:788-93.
34. Yoshimura T, Matsushima K, Tanaka S, Robinson EA, Appella E, Oppenhein JJ, et al. Purification of a human monocyte-derived neutrophil chemotactic factor that has peptide sequence similarity to other host defense cytokines. Proc Natl Acad Sci USA 1987; 84:9233-7.
35. Verghese MW, Snyderman RS. Role of chemotactic and inflammatory cytokines. In: Oppenheim JJ, Sfevach E, editor. Text book of Immunology. New York: Oxford University, 1989:274-305.
36. Firestein GS, Boyle DL, Yu C, Paine MM, Whisenand TD, Zvaifler NJ, et al. Synovial interleukin-1 receptor antagonist and interleukin-1 balance in rheumatoid arthritis. Arthritis Rheum 1994;37:644-52.
37. Chomarat P, Vannier E, Dechanet J, Rissoan MC, Banchereau J, Dinarello CA, et al. Balance of IL-1 receptor antagonist/IL-1b in rheumatoid synovium and its regulation by IL-4 and IL-10. J Immunol 1995;154:1432-9.
38. Casini RV, Kam L, Chong YJ, Fiocchi C, Pizarro TT, Cominelli F. Mucosal imbalance of IL-1 and IL-1 receptor antagonist in inflammatory bowel disease. A novel mechanism of chronic intestinal inflammation. J Immunol 1995;154:2434-40.
39. Fukumoto T, Matsukawa A, Ohkawara S, Takagi K, Yoshinaga M. Administration of neutralizing antibody against rabbit IL-1 receptor antagonist exacerbates lipopolysaccharide-induced arthritis in rabbits. Inflamm Res 1996;45:479-85.
40. Chensue SW, Bienkowski M, Eessalu TE, Warmington KS, Hershey SD, Lukacs NW, et al. Endogenous IL-1 receptor antagonist protein (IRAP) regulates schistosome egg granuloma formation and the regional lymphoid response. J Immunol 1993;151:3654-62.
41. Ferretti M, Casini RV, Pizarro TT, Eisenberg SP, Nast CC, Cominelli F. Neutralization of endogenous IL-1 receptor antagonist exacerbates and prolongs inflammation in rabbit immune colitis. J Clin Invest 1994;94:449-53.
42. Fujioka N, Mukaida N, Harada A, Akiyama M, Kasahara T, Kuno K, et al. Preparation of specific antibodies against murine IL-1ra and the establishment of IL-1ra as an endogenous regulator of bacteria-induced fulminant hepatitis in mice. J Leukoc Biol 1995;58:90-8.
43. Miyamoto K, Matsukawa A, Ohkawara S, Takagi K, Yoshinaga M. IL-8 is involved in homologous TNFα-, but not in IL-1β-induced neutrophil infiltration in rabbits. Inflamm Res 1997;46: 472-7.
44. Henderson B, Pettipher ER. Arthritogenic actions of recombinant IL-1 and tumour necrosis factor alpha in the rabbit: evidence for synergistic interactions between cytokines in vivo. Clin Exp Immunol 1989;75:306-10.
45. O'Byrne EM, Blancuzzi V, Wilson DE, Wong M, Jeng AY. Elevated substance P and accelerated cartilage degradation in rabbit knees injected with interleukin-1 and tumor necrosis factor. Arthritis Rheum 1990;33:1023-8.
46. Akahoshi T, Endo H, Kondo H, Kashiwazaki S, Kasahara T, Mukaida N, et al. Essential involvement of interleukin-8 in neutrophil recruitment in rabbits with acute experimental arthritis induced by lipopolysaccharide and interleukin-1. Lymphokine Cytokine Res 1994;13:113-6.
47. Vassalli P. The pathophysiology of tumor necrosis factors. Annu Rev Immunol 1992;10:411-52.
48. Saukkonen K, Sande S, Cioffe C, Wolpe S, Sherry B, Cerami A, et al. The role of cytokines in the generation of inflammation and tissue damage in experimental gram-positive meningitis. J Exp Med 1990;171:439-48.
49. Mori S, Goto F, Goto K, Ohkawara S, Maeda S, Shimada K, et al. Cloning and sequence analysis of a cDNA for lymphocyte proliferation potentiating factor of rabbit polymorphonuclear leukocytes: identification rabbit interleukin 1 beta. Biochem Biophys Res Commun 1988;150:1237-43.
50. Larsen CG, Anderson AO, Appella E, Oppenheim JJ, Matsushima K. The neutrophil-activating protein (NAP-1) is also chemotactic for T lymphocytes. Science 1989;243:1464-66.
51. Baggiolini M, Dewald B, Moser B. Interleukin-8 and related chemotactic cytokines - CXC and CC chemokines. Adv Immunol 1994;55:97-179.
52. Dinarello CA. The biological properties of interleukin-1. Eur Cytokine Netw 1994;5:517-31.
53. Tracey KJ, Cerami A. Tumor necrosis factor: A pleiotropic cytokine and therapeutic target. Annu Rev Med 1994;45:491-503.
54. Brennan FM, Chantry D, Jackson A, Maini R, Feldmann M. Inhibitory effect of TNFα antibodies on synovial cell interleukin-1 production in rheumatoid arthritis. Lancet 1989;2:244-7.
55. Standiford TJ, Kunkel SL, Basha MA, Chensue SW, Lynch JP, Toews GB, et al. Interleukin-8 gene expression by a pulmonary epithelial cell line. A model for cytokine networks in the lung. J Clin Invest 1990;86:1945-53.
56. Porat R, Poutsiaka DD, Miller LC, Granowitz EV, Dinarello CA. Interleukin-1 (IL-1) receptor blockade reduces endotoxin and Borrelia burgdorferi-stimulated IL-8 synthesis in human mononuclear cells. FASEB J 1992;6:2482-6.
57. Van ZK, DeForge LE, Fischer E, Marano MA, Kenney JS, Remick DG, et al. IL-8 in septic shock, endotoxemia, and after IL-1 administration. J Immunol 1991;146:3478-82.
58. Sheron N, Williams R. IL-8 as a circulating cytokine: Induction by recombinant tumour necrosis factor-alpha. Clin Exp Immunol 1992;89:100-3.
59. Van ZK, Fischer E, Hawes AS, Hebert CA, Terrell TG, Baker JB, et al. Effects of intravenous IL-8 administration in nonhuman primates. J Immunol 1992;148:1746-52.
60. Endo H, Akahoshi T, Takagishi K, Kashiwazaki S, Matsushima K. Elevation of interleukin-8 (IL-8) levels in joint fluids of patients with rheumatoid arthritis and the induction by IL-8 of leukocyte infiltration and synovitis in rabbit joints. Lymphokine Cytokine Res 1991;10:245-52.
61. Granowitz EV, Santos AA, Poutsiaka DD, Cannon JG, Wilmore DW, Wolff SM, et al. Production of interleukin-1-receptor antagonist during experimental endotoxaemia. Lancet 1991;338: 1423-4.